Atlas Trials

Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors

Clinical trial NCT02375204 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02375204
Sponsor
Alliance for Clinical Trials in Oncology
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Germ Cell TumorTeratomaChoriocarcinomaGerminomaMixed Germ Cell TumorYolk Sac TumorChildhood TeratomaMalignant Germ Cell NeoplasmExtragonadal SeminomaNon-seminomatous Germ Cell TumorSeminoma
Start date
2015-08-06
Primary completion
2031-06-01
Enrollment
420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.